Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Viral Vectors and Plasmid DNA Manufacturing market size will reach 1,077.39 Million USD in 2025 and is projected to reach 3,303.80 Million USD by 2032, with a CAGR of 17.36% (2025-2032). Notably, the China Viral Vectors and Plasmid DNA Manufacturing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Viral vectors and plasmid DNA manufacturing are integral processes in the production of gene therapy and vaccines. Viral vectors are modified viruses engineered to deliver therapeutic genes into target cells, while plasmid DNA serves as a vehicle for carrying genetic material into cells. The manufacturing process involves multiple steps, including vector or plasmid design, cell culture, transfection, purification, and quality control. For viral vectors, the chosen viral backbone is modified to remove its ability to replicate and cause disease, while retaining its ability to efficiently deliver genetic material into host cells. Plasmid DNA is produced by cloning the target gene into a bacterial plasmid, followed by large-scale bacterial fermentation and purification. Both viral vectors and plasmid DNA undergo rigorous quality control testing to ensure purity, potency, and safety before being used in clinical applications. These manufacturing processes require adherence to strict regulatory guidelines to ensure the safety and efficacy of gene therapy and vaccine products. As the field of gene therapy continues to advance, optimized manufacturing techniques are crucial to meet the growing demand for these innovative treatments.
The major global suppliers of Viral Vectors and Plasmid DNA Manufacturing include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Viral Vectors and Plasmid DNA Manufacturing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Viral Vectors and Plasmid DNA Manufacturing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Viral Vectors and Plasmid DNA Manufacturing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Viral Vectors and Plasmid DNA Manufacturing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Viral Vectors and Plasmid DNA Manufacturing Include:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Viral Vectors and Plasmid DNA Manufacturing Product Segment Include:
Plasmid DNA
Viral Vectors
Viral Vectors and Plasmid DNA Manufacturing Product Application Include:
Cancers
Inherited Disorders
Viral Infections
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Viral Vectors and Plasmid DNA Manufacturing Industry PESTEL Analysis
Chapter 3: Global Viral Vectors and Plasmid DNA Manufacturing Industry Porter's Five Forces Analysis
Chapter 4: Global Viral Vectors and Plasmid DNA Manufacturing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Viral Vectors and Plasmid DNA Manufacturing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Viral Vectors and Plasmid DNA Manufacturing market size will reach 1,077.39 Million USD in 2025 and is projected to reach 3,303.80 Million USD by 2032, with a CAGR of 17.36% (2025-2032). Notably, the China Viral Vectors and Plasmid DNA Manufacturing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Viral vectors and plasmid DNA manufacturing are integral processes in the production of gene therapy and vaccines. Viral vectors are modified viruses engineered to deliver therapeutic genes into target cells, while plasmid DNA serves as a vehicle for carrying genetic material into cells. The manufacturing process involves multiple steps, including vector or plasmid design, cell culture, transfection, purification, and quality control. For viral vectors, the chosen viral backbone is modified to remove its ability to replicate and cause disease, while retaining its ability to efficiently deliver genetic material into host cells. Plasmid DNA is produced by cloning the target gene into a bacterial plasmid, followed by large-scale bacterial fermentation and purification. Both viral vectors and plasmid DNA undergo rigorous quality control testing to ensure purity, potency, and safety before being used in clinical applications. These manufacturing processes require adherence to strict regulatory guidelines to ensure the safety and efficacy of gene therapy and vaccine products. As the field of gene therapy continues to advance, optimized manufacturing techniques are crucial to meet the growing demand for these innovative treatments.
The major global suppliers of Viral Vectors and Plasmid DNA Manufacturing include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Viral Vectors and Plasmid DNA Manufacturing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Viral Vectors and Plasmid DNA Manufacturing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Viral Vectors and Plasmid DNA Manufacturing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Viral Vectors and Plasmid DNA Manufacturing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Viral Vectors and Plasmid DNA Manufacturing Include:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Viral Vectors and Plasmid DNA Manufacturing Product Segment Include:
Plasmid DNA
Viral Vectors
Viral Vectors and Plasmid DNA Manufacturing Product Application Include:
Cancers
Inherited Disorders
Viral Infections
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Viral Vectors and Plasmid DNA Manufacturing Industry PESTEL Analysis
Chapter 3: Global Viral Vectors and Plasmid DNA Manufacturing Industry Porter's Five Forces Analysis
Chapter 4: Global Viral Vectors and Plasmid DNA Manufacturing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Viral Vectors and Plasmid DNA Manufacturing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Viral Vectors and Plasmid DNA Manufacturing Product by Type
- 1.2.1 Plasmid DNA
- 1.2.2 Viral Vectors
- 1.3 Viral Vectors and Plasmid DNA Manufacturing Product by Application
- 1.3.1 Cancers
- 1.3.2 Inherited Disorders
- 1.3.3 Viral Infections
- 1.3.4 Others
- 1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Analysis (2020-2032)
- 1.5 Viral Vectors and Plasmid DNA Manufacturing Market Development Status and Trends
- 1.5.1 Viral Vectors and Plasmid DNA Manufacturing Industry Development Status Analysis
- 1.5.2 Viral Vectors and Plasmid DNA Manufacturing Industry Development Trends Analysis
- 2 Viral Vectors and Plasmid DNA Manufacturing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Viral Vectors and Plasmid DNA Manufacturing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Country
- 4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.5 China Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.6 France Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.14 India Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Revenue by Key Suppliers (2021-2025)
- 5.2 Viral Vectors and Plasmid DNA Manufacturing Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Viral Vectors and Plasmid DNA Manufacturing Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Type
- 6.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 BioReliance
- 7.1.1 BioReliance Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Cobra Biologics
- 7.2.1 Cobra Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Oxford BioMedica
- 7.3.1 Oxford BioMedica Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 UniQure
- 7.4.1 UniQure Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 FinVector
- 7.5.1 FinVector Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 MolMed
- 7.6.1 MolMed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 MassBiologics
- 7.7.1 MassBiologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Richter-Helm
- 7.8.1 Richter-Helm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 FUJIFILM Diosynth Biotechnologies
- 7.9.1 FUJIFILM Diosynth Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Lonza
- 7.10.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Aldevron
- 7.11.1 Aldevron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Eurogentec
- 7.12.1 Eurogentec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Cell and Gene Therapy Catapult
- 7.13.1 Cell and Gene Therapy Catapult Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Biovian
- 7.14.1 Biovian Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Thermo Fisher Scientific (Brammer Bio)
- 7.15.1 Thermo Fisher Scientific (Brammer Bio) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 VGXI
- 7.16.1 VGXI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 PlasmidFactory
- 7.17.1 PlasmidFactory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 7.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Viral Vectors and Plasmid DNA Manufacturing Industry Chain Analysis
- 8.2 Viral Vectors and Plasmid DNA Manufacturing Product Downstream Application Analysis
- 8.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Forecast by Application (2020-2032)
- 8.3 Viral Vectors and Plasmid DNA Manufacturing Typical Downstream Customers
- 8.4 Viral Vectors and Plasmid DNA Manufacturing Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
